UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $337, UP FROM $315
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy UNH?
Source: moomoo
Global Health Research Funding: The United Health Foundation has raised its funding objective for global health research to $337 million, an increase from the previous target of $315 million.
Focus on Health Initiatives: The additional funds are aimed at enhancing health initiatives and addressing critical health challenges worldwide.
Impact on Communities: The funding is expected to support various programs that improve health outcomes in underserved communities globally.
Commitment to Health Equity: This increase reflects a commitment to promoting health equity and advancing research that can lead to better health solutions for diverse populations.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 307.730
Low
330.00
Averages
397.82
High
444.00
Current: 307.730
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Shares Surge 8% on Medicare Payment Update
- Medicare Payment Increase: The Centers for Medicare & Medicaid Services confirmed a 2.48% increase in Medicare Advantage payments for 2027, improving from the nearly flat rate proposed in January, alleviating concerns about profit margins.
- Positive Stock Reaction: UnitedHealth's shares surged nearly 8% in after-hours trading on Monday, indicating investor optimism regarding the new payment policy, which could enhance the company's profitability and market confidence.
- Shareholder Structure Analysis: According to TipRanks data, public companies and individual investors hold about 49% of UnitedHealth, while mutual funds and ETFs account for nearly 27% and 22%, respectively, indicating a broad investor base.
- Major Shareholder Insights: Vanguard holds the largest stake at approximately 9%, with the Vanguard Total Stock Market ETF (VTI) owning over 3% and the Vanguard S&P 500 ETF (VOO) holding about 2.6%, reflecting institutional investors' significant interest in the company.
See More
UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $337, UP FROM $315
Global Health Research Funding: The United Health Foundation has raised its funding objective for global health research to $337 million, an increase from the previous target of $315 million.
Focus on Health Initiatives: The additional funds are aimed at enhancing health initiatives and addressing critical health challenges worldwide.
Impact on Communities: The funding is expected to support various programs that improve health outcomes in underserved communities globally.
Commitment to Health Equity: This increase reflects a commitment to promoting health equity and advancing research that can lead to better health solutions for diverse populations.
See More
UnitedHealth Group Shares Snap Six-Day Gain
- Stock Pullback: UnitedHealth Group (UNH) shares fell 0.5% to $306.14 on Wednesday, ending a six-day gain streak during which the stock rose over 17%, indicating short-term volatility despite recent strong performance.
- Medicare Payment Increase: The Trump administration's announcement to raise average Medicare Advantage payments by 2.48%, or over $13 billion, in 2027 has positively impacted UNH and other healthcare insurance stocks, reflecting the favorable implications of policy changes on the industry.
- Analyst Ratings: According to Seeking Alpha's Quant Rating, UNH holds a 'Hold' rating with a score of 3.3, where it received an A+ for profitability prospects but an F for growth factors, indicating market concerns regarding its future growth potential.
- Market Opportunity: Analysts highlight that UNH remains undervalued by approximately 10% even under conservative assumptions, presenting a market-beating investment opportunity despite execution and regulatory risks, showcasing its attractiveness in the current market landscape.
See More
Trump Announces U.S.-Iran Ceasefire Agreement
- Market Surge: Following Trump's announcement of a two-week ceasefire between the U.S. and Iran, stocks soared, with S&P 500 futures rising sharply, reflecting market optimism about the potential end of the conflict.
- Crude Price Plunge: The ceasefire led to an 18% drop in West Texas Intermediate futures to around $92 per barrel, while Brent oil fell 16.7%, alleviating inflationary pressures and potentially boosting consumer spending.
- Airline Stocks Rally: Lower crude prices resulted in significant gains for airlines, with United Airlines up over 12% and Delta Air Lines rising about 11%, indicating that reduced fuel costs could enhance profitability and stimulate travel demand.
- Tech Stocks Strengthen: Stocks like Sandisk and On Semiconductor, identified by JPMorgan as inversely correlated with WTI, saw premarket gains of 9% and 5% respectively, suggesting renewed investor confidence in technology amid the positive market sentiment.
See More
HSBC Upgrades UNITEDHEALTH to Hold and Increases Target Price to $300 from $255
United Health and HSBC Update: United Health has raised its target price to $300 from $255, indicating a positive outlook for the company's performance.
Stock Performance: The adjustment in target price reflects a recovery from previous reductions, suggesting confidence in United Health's future growth.
See More
BofA Raises UnitedHealth Price Target to $337 Amid Medicare Rate Hike
- Price Target Increase: BofA analyst Kevin Fischbeck raised UnitedHealth's (UNH) price target from $315 to $337 while maintaining a Neutral rating, reflecting a cautiously optimistic outlook on the company's future performance.
- Medicare Advantage Benefit: The price target increase is attributed to CMS finalizing the 2027 Medicare Advantage rates, which provides clear visibility on future rates, indicating the positive impact of policy stability on the company's valuation.
- Rate Growth Exceeds Expectations: The analyst noted that the net increase of 2.48% in rates surpasses the market's expected range of 1%-2%, which will help enhance UnitedHealth's revenue and profitability.
- Industry Impact: BofA also raised price targets for several managed care companies, suggesting that the valuation levels across the industry may improve in light of changes in Medicare policy, thereby boosting investor confidence in healthcare stocks.
See More
UnitedHealth Shares Surge 8% on Medicare Payment Update
- Medicare Payment Increase: The Centers for Medicare & Medicaid Services confirmed a 2.48% increase in Medicare Advantage payments for 2027, improving from the nearly flat rate proposed in January, alleviating concerns about profit margins.
- Positive Stock Reaction: UnitedHealth's shares surged nearly 8% in after-hours trading on Monday, indicating investor optimism regarding the new payment policy, which could enhance the company's profitability and market confidence.
- Shareholder Structure Analysis: According to TipRanks data, public companies and individual investors hold about 49% of UnitedHealth, while mutual funds and ETFs account for nearly 27% and 22%, respectively, indicating a broad investor base.
- Major Shareholder Insights: Vanguard holds the largest stake at approximately 9%, with the Vanguard Total Stock Market ETF (VTI) owning over 3% and the Vanguard S&P 500 ETF (VOO) holding about 2.6%, reflecting institutional investors' significant interest in the company.
See More
UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $337, UP FROM $315
Global Health Research Funding: The United Health Foundation has raised its funding objective for global health research to $337 million, an increase from the previous target of $315 million.
Focus on Health Initiatives: The additional funds are aimed at enhancing health initiatives and addressing critical health challenges worldwide.
Impact on Communities: The funding is expected to support various programs that improve health outcomes in underserved communities globally.
Commitment to Health Equity: This increase reflects a commitment to promoting health equity and advancing research that can lead to better health solutions for diverse populations.
See More
UnitedHealth Group Shares Snap Six-Day Gain
- Stock Pullback: UnitedHealth Group (UNH) shares fell 0.5% to $306.14 on Wednesday, ending a six-day gain streak during which the stock rose over 17%, indicating short-term volatility despite recent strong performance.
- Medicare Payment Increase: The Trump administration's announcement to raise average Medicare Advantage payments by 2.48%, or over $13 billion, in 2027 has positively impacted UNH and other healthcare insurance stocks, reflecting the favorable implications of policy changes on the industry.
- Analyst Ratings: According to Seeking Alpha's Quant Rating, UNH holds a 'Hold' rating with a score of 3.3, where it received an A+ for profitability prospects but an F for growth factors, indicating market concerns regarding its future growth potential.
- Market Opportunity: Analysts highlight that UNH remains undervalued by approximately 10% even under conservative assumptions, presenting a market-beating investment opportunity despite execution and regulatory risks, showcasing its attractiveness in the current market landscape.
See More
Trump Announces U.S.-Iran Ceasefire Agreement
- Market Surge: Following Trump's announcement of a two-week ceasefire between the U.S. and Iran, stocks soared, with S&P 500 futures rising sharply, reflecting market optimism about the potential end of the conflict.
- Crude Price Plunge: The ceasefire led to an 18% drop in West Texas Intermediate futures to around $92 per barrel, while Brent oil fell 16.7%, alleviating inflationary pressures and potentially boosting consumer spending.
- Airline Stocks Rally: Lower crude prices resulted in significant gains for airlines, with United Airlines up over 12% and Delta Air Lines rising about 11%, indicating that reduced fuel costs could enhance profitability and stimulate travel demand.
- Tech Stocks Strengthen: Stocks like Sandisk and On Semiconductor, identified by JPMorgan as inversely correlated with WTI, saw premarket gains of 9% and 5% respectively, suggesting renewed investor confidence in technology amid the positive market sentiment.
See More
HSBC Upgrades UNITEDHEALTH to Hold and Increases Target Price to $300 from $255
United Health and HSBC Update: United Health has raised its target price to $300 from $255, indicating a positive outlook for the company's performance.
Stock Performance: The adjustment in target price reflects a recovery from previous reductions, suggesting confidence in United Health's future growth.
See More
BofA Raises UnitedHealth Price Target to $337 Amid Medicare Rate Hike
- Price Target Increase: BofA analyst Kevin Fischbeck raised UnitedHealth's (UNH) price target from $315 to $337 while maintaining a Neutral rating, reflecting a cautiously optimistic outlook on the company's future performance.
- Medicare Advantage Benefit: The price target increase is attributed to CMS finalizing the 2027 Medicare Advantage rates, which provides clear visibility on future rates, indicating the positive impact of policy stability on the company's valuation.
- Rate Growth Exceeds Expectations: The analyst noted that the net increase of 2.48% in rates surpasses the market's expected range of 1%-2%, which will help enhance UnitedHealth's revenue and profitability.
- Industry Impact: BofA also raised price targets for several managed care companies, suggesting that the valuation levels across the industry may improve in light of changes in Medicare policy, thereby boosting investor confidence in healthcare stocks.
See More
